130
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Effects of anti-diabetic drugs on bone metabolism

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ryan A. Lafferty, Peter R. Flatt & Nigel Irwin. (2023) GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy. Expert Opinion on Pharmacotherapy 24:5, pages 587-597.
Read now

Articles from other publishers (12)

N. V. Bulushova, I. A. Zalunin, A. S. Asrarkulova & D. G. Kozlov. (2022) Incretin Analogues in the Therapy of Type 2 Diabetes and Obesity. Applied Biochemistry and Microbiology 58:7, pages 854-863.
Crossref
Ryan A. Lafferty, Finbarr P.M. O’Harte, Nigel Irwin, Peter R. Flatt & Victor A. Gault. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 301 343 .
Shruti Mohan, Peter R. Flatt, Nigel Irwin & R. Charlotte Moffett. (2021) Weight‐reducing, lipid‐lowering and antidiabetic activities of a novel arginine vasopressin analogue acting at the V1a and V1b receptors in high‐fat‐fed mice. Diabetes, Obesity and Metabolism 23:10, pages 2215-2225.
Crossref
Shruti Mohan, Andrew G. McCloskey, Aine M. McKillop, Peter R. Flatt, Nigel Irwin & R. Charlotte Moffett. (2021) Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:3, pages 129811.
Crossref
I.A. ZaluninA.S. AsrarkulovaD.G. Kozlov. (2021) Incretin Analogues in Therapy of Type 2 Diabetes and Obesity. Biotekhnologiya 37:3, pages 53-64.
Crossref
Elham Rajaei, Habib Haybar, Karim Mowla & Zeinab D. Zayeri. (2019) Metformin one in a Million Efficient Medicines for Rheumatoid Arthritis Complications: Inflammation, Osteoblastogenesis, Cardiovascular Disease, Malignancies. Current Rheumatology Reviews 15:2, pages 116-122.
Crossref
Sity Aishah Mansur, Aleksandra Mieczkowska, Peter R. Flatt, Daniel Chappard, Nigel Irwin & Guillaume Mabilleau. (2019) The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice. Frontiers in Endocrinology 10.
Crossref
Guillaume Mabilleau, Benoît Gobron, Béatrice Bouvard & Daniel Chappard. (2018) Incretin-based therapy for the treatment of bone fragility in diabetes mellitus. Peptides 100, pages 108-113.
Crossref
V. A. Gault. (2018) RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes . Diabetic Medicine 35:1, pages 33-40.
Crossref
G. Mabilleau. (2017) Interplay between bone and incretin hormones: A review. Morphologie 101:332, pages 9-18.
Crossref
Guillaume Mabilleau, Rodolphe Perrot, Aleksandra Mieczkowska, S?bastien Boni, Peter R. Flatt, Nigel Irwin & Daniel Chappard. (2016) Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption. Bone 91, pages 102-112.
Crossref
Guillaume Mabilleau, Rodolphe Perrot, Peter R. Flatt, Nigel Irwin & Daniel Chappard. (2016) High fat-fed diabetic mice present with profound alterations of the osteocyte network. Bone 90, pages 99-106.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.